180 related articles for article (PubMed ID: 28457731)
1. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of G
Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
[TBL] [Abstract][Full Text] [Related]
3. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma.
Itou RA; Uyama N; Hirota S; Kawada N; Wu S; Miyashita S; Nakamura I; Suzumura K; Sueoka H; Okada T; Hatano E; Tsutsui H; Fujimoto J
Hum Pathol; 2019 Jan; 83():77-89. PubMed ID: 30172911
[TBL] [Abstract][Full Text] [Related]
5. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
6. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Jun; 14(23):3739-44. PubMed ID: 18595142
[TBL] [Abstract][Full Text] [Related]
9. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer.
Son GM; Kwon MS; Shin DH; Shin N; Ryu D; Kang CD
Medicine (Baltimore); 2019 May; 98(18):e15164. PubMed ID: 31045759
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Sakata J; Matsuda Y; Korita PV; Takamura M; Ajioka Y; Hatakeyama K
Int J Clin Exp Pathol; 2011 Apr; 4(4):363-70. PubMed ID: 21577322
[TBL] [Abstract][Full Text] [Related]
12. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
[TBL] [Abstract][Full Text] [Related]
13. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C
Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma.
Gu MJ; Choi JH
J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.
Zhao XQ; Ma HX; Su MS; He L
Int J Clin Exp Pathol; 2014; 7(10):6914-21. PubMed ID: 25400775
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C
J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]